How to Read "ADHD Drug Evidence Is Weak" Headlines — Cochrane Systematic Review (2023)
3-Line Summary
- What: Cochrane rated the certainty of evidence for methylphenidate as "very low."
- Who: Risk of bias, under-reporting of side effects, and study heterogeneity were the main reasons.
- Result: This means "hard to say with certainty," not "it doesn't work."
Keywords
methylphenidate Cochrane evidence-certainty very-low-certainty bias
Action Tips
- Don't just read the headline — check the reviewing organization and their criteria.
- Ask your doctor about the latest evidence.